Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study.

Schahrasad Lisa Ridha AliAnne-Marie GlimmGerd-Rüdiger R BurmesterPaula HoffGabriela SchmittatSandra HermannMarina BackhausJens KlotscheSarah Ohrndorf

Published in: BMJ open (2021)

US7 GS synovitis score and FOI in PVM are able to discriminate between patients with and without need for RTX retherapy better than clinical and laboratory parameters.

Keyphrases

rheumatoid arthritis
high resolution
diffuse large b cell lymphoma
disease activity
single molecule
high speed
interstitial lung disease
ankylosing spondylitis
chronic lymphocytic leukemia
photodynamic therapy